Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy

PURPOSE/BACKGROUND: Dopamine receptor blocking agents (DRBAs), also known as antipsychotics, are medications widely used to treat a growing number of mental health diagnoses. However, their utility is limited by the potential to cause serious adverse movement reactions. Akathisia, dystonia, parkinso...

Descripción completa

Detalles Bibliográficos
Autores principales: Musco, Shaina, Ruekert, Laura, Myers, Jaclyn, Anderson, Dennis, Welling, Michael, Cunningham, Elizabeth Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594730/
https://www.ncbi.nlm.nih.gov/pubmed/31205194
http://dx.doi.org/10.1097/JCP.0000000000001061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594730/
https://www.ncbi.nlm.nih.gov/pubmed/31205194
http://dx.doi.org/10.1097/JCP.0000000000001061

Ejemplares similares